Dean Schorno
Director of Finance/CFO chez RIGEL PHARMACEUTICALS, INC.
Fortune : 596 279 $ au 31/03/2024
Profil
Dean L.
Schorno is the Chief Financial Officer & Executive Vice President at Rigel Pharmaceuticals, Inc. He previously worked as the Chief Financial Officer & Head-Investor Relations at Genomic Health, Inc. from 2011 to 2014, the Chief Financial Officer & Head-Operations at 23andMe, Inc. from 2015 to 2018, and the Chief Financial Officer at Adaptive Biotechnologies Corp.
in 2014 to 2015.
Schorno has a graduate degree from Golden Gate University and an undergraduate degree from the University of California, Berkeley.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/02/2024 | 402 891 ( 0,23% ) | 596 279 $ | 31/03/2024 |
Postes actifs de Dean Schorno
| Sociétés | Poste | Début |
|---|---|---|
| RIGEL PHARMACEUTICALS, INC. | Director of Finance/CFO | 29/05/2018 |
Anciens postes connus de Dean Schorno
| Sociétés | Poste | Fin |
|---|---|---|
23andMe, Inc.
 23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Director of Finance/CFO | 01/05/2018 |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Director of Finance/CFO | 10/08/2015 |
| GENOMIC HEALTH, INC. | Director of Finance/CFO | 01/07/2014 |
Formation de Dean Schorno
| Golden Gate University | Graduate Degree |
| University of California, Berkeley | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| RIGEL PHARMACEUTICALS, INC. | Health Technology |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Health Technology |
| Entreprise privées | 2 |
|---|---|
Genomic Health, Inc.
 Genomic Health, Inc. Medical SpecialtiesHealth Technology Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. The company was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA. | Health Technology |
23andMe, Inc.
23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Health Technology |
